Cyclacel Announces First Patient Dosed in IST of CDK Inhibitor Seliciclib in Cushing's Disease,
July 02, 2015 at 07:04 AM EDT
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP) today announced that the first patient has been dosed in an investigator ...
